SINOVAC BIOTECH LTD (SVA) › Capital ExpendituresSINOVAC BIOTECH LTD (SVA) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2009: $4.32M2010: $24.82M2011: $15.46M2012: $16.16M2013: $5.13M2014: $10.91M2015: $5.30M2016: $12.65M2017: $11.91M2018: $5.61M2019: $10.63M2020: $127.49M2021: $594.21M2022: $313.86M2023: $156.16M2024: $95.96M2025: $48.92M$48.92M2009Capital Expenditures (USD)2025Fiscal YearCapital ExpendituresChange YoY2025$48.92M-49.0%2024$95.96M-38.6%2023$156.16M-50.2%2022$313.86M-47.2%2021$594.21M+366.1%2020$127.49M+1099.5%2019$10.63M+89.3%2018$5.61M-52.9%2017$11.91M-5.8%2016$12.65M+138.8%2015$5.30M-51.4%2014$10.91M+112.6%2013$5.13M-68.2%2012$16.16M+4.5%2011$15.46M-37.7%2010$24.82M+474.5%2009$4.32M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share